XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Total W.P. Carey Stockholders
$0.001 Par Value Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Earnings
Deferred Compensation Obligation
Accumulated Other Comprehensive Loss
Noncontrolling interests
Beginning equity balance at Dec. 31, 2021 $ 7,583,451 $ 7,581,785 $ 190 $ 9,977,686 $ (2,224,231) $ 49,810 $ (221,670) $ 1,666
Beginning equity balance (in shares) at Dec. 31, 2021     190,013,751          
W.P. Carey Stockholders                
Shares issued to stockholders of CPA:18 – Global in connection with CPA:18 Merger 1,205,750 1,205,750 $ 14 1,205,736        
Shares issued to stockholders of CPA:18 – Global in connection with CPA:18 Merger, (in shares)     13,786,302          
Shares issued under our prior ATM Program, net 218,101 218,101 $ 3 218,098        
Shares issued under our prior ATM Program, net (in shares)     2,740,295          
Shares issued under forward equity, net 97,455 97,455 $ 1 97,454        
Shares issued under ATM Forwards, net, (in shares)     1,337,500          
Shares issued upon delivery of vested restricted share awards (6,612) (6,612)   (6,612)        
Shares issued upon delivery of vested restricted share awards (in shares)     152,830          
Shares issued upon purchases under employee share purchase plan (in shares)     2,040          
Shares issued upon purchases under employee share purchase plan 155 155   155        
Amortization of stock-based compensation expense 23,102 23,102   23,102        
Deferral of vested shares, net 0 0   (6,696)   6,696    
Acquisition of noncontrolling interest 14,367             14,367
Distributions to noncontrolling interests (176)             (176)
Dividends declared (633,745) (633,745)   1,380 (635,631) 506    
Net income 388,979 389,601     389,601     (622)
Other comprehensive income (loss):                
Foreign currency translation adjustments (109,198) (108,655)         (108,655) (543)
Unrealized gain (loss) on derivative instruments 50,956 50,956         50,956  
Reclassification of unrealized gain on investments to net income (18,688) (18,688)         (18,688)  
Ending equity balance (in shares) at Sep. 30, 2022     208,032,718          
Ending equity balance at Sep. 30, 2022 8,813,897 8,799,205 $ 208 11,510,303 (2,470,261) 57,012 (298,057) 14,692
Beginning equity balance at Jun. 30, 2022 7,641,462 7,639,823 $ 193 10,201,614 (2,352,839) 57,012 (266,157) 1,639
Beginning equity balance (in shares) at Jun. 30, 2022     192,891,792          
W.P. Carey Stockholders                
Shares issued to stockholders of CPA:18 – Global in connection with CPA:18 Merger 1,205,750 1,205,750 $ 14 1,205,736        
Shares issued to stockholders of CPA:18 – Global in connection with CPA:18 Merger, (in shares)     13,786,302          
Shares issued under forward equity, net 97,455 97,455 $ 1 97,454        
Shares issued under ATM Forwards, net, (in shares)     1,337,500          
Shares issued upon delivery of vested restricted share awards (12) (12)   (12)        
Shares issued upon delivery of vested restricted share awards (in shares)     17,124          
Amortization of stock-based compensation expense 5,511 5,511   5,511        
Acquisition of noncontrolling interest 14,367             14,367
Distributions to noncontrolling interests (111)             (111)
Dividends declared (222,350) (222,350)     (222,350)      
Net income 104,268 104,928     104,928     (660)
Other comprehensive income (loss):                
Foreign currency translation adjustments (56,053) (55,510)         (55,510) (543)
Unrealized gain (loss) on derivative instruments 23,610 23,610         23,610  
Reclassification of unrealized gain on investments to net income 0              
Ending equity balance (in shares) at Sep. 30, 2022     208,032,718          
Ending equity balance at Sep. 30, 2022 8,813,897 8,799,205 $ 208 11,510,303 (2,470,261) 57,012 (298,057) 14,692
Beginning equity balance at Dec. 31, 2022 $ 9,008,644 8,993,646 $ 211 11,706,836 (2,486,633) 57,012 (283,780) 14,998
Beginning equity balance (in shares) at Dec. 31, 2022 210,620,949   210,620,949          
W.P. Carey Stockholders                
Shares issued under forward equity, net $ 249,863 249,863 $ 3 249,860        
Shares issued under ATM Forwards, net, (in shares)     3,081,867          
Shares issued upon delivery of vested restricted share awards (13,679) (13,679)   (13,679)        
Shares issued upon delivery of vested restricted share awards (in shares)     218,266          
Shares issued upon purchases under employee share purchase plan (in shares)     4,735          
Shares issued upon purchases under employee share purchase plan 294 294   294        
Amortization of stock-based compensation expense 25,811 25,811   25,811        
Deferral of vested shares, net       (4,521)   4,521    
Acquisition of noncontrolling interest 0 3,663   3,663       (3,663)
Contributions from noncontrolling interests 2,886             2,886
Distributions to noncontrolling interests (3,059)             (3,059)
Dividends declared (691,237) (691,237)   2,295 (694,045) 513    
Net income 564,020 564,040     564,040     (20)
Other comprehensive income (loss):                
Foreign currency translation adjustments 7,092 7,344         7,344 (252)
Unrealized gain (loss) on derivative instruments (5,384) (5,384)         (5,384)  
Reclassification of unrealized gain on investments to net income $ 0              
Ending equity balance (in shares) at Sep. 30, 2023 213,925,817   213,925,817          
Ending equity balance at Sep. 30, 2023 $ 9,145,251 9,134,361 $ 214 11,970,559 (2,616,638) 62,046 (281,820) 10,890
Beginning equity balance at Jun. 30, 2023 9,246,932 9,230,573 $ 214 11,959,060 (2,510,816) 62,046 (279,931) 16,359
Beginning equity balance (in shares) at Jun. 30, 2023     213,901,170          
W.P. Carey Stockholders                
Shares issued upon delivery of vested restricted share awards (61) (61)   (61)        
Shares issued upon delivery of vested restricted share awards (in shares)     24,647          
Amortization of stock-based compensation expense 9,050 9,050   9,050        
Acquisition of noncontrolling interest 0 2,510   2,510       (2,510)
Distributions to noncontrolling interests (2,779)             (2,779)
Dividends declared (230,862) (230,862)     (230,862)      
Net income 124,999 125,040     125,040     (41)
Other comprehensive income (loss):                
Foreign currency translation adjustments (8,844) (8,705)         (8,705) (139)
Unrealized gain (loss) on derivative instruments 6,816 6,816         6,816  
Reclassification of unrealized gain on investments to net income $ 0              
Ending equity balance (in shares) at Sep. 30, 2023 213,925,817   213,925,817          
Ending equity balance at Sep. 30, 2023 $ 9,145,251 $ 9,134,361 $ 214 $ 11,970,559 $ (2,616,638) $ 62,046 $ (281,820) $ 10,890